Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 212

1.

Reduction of lipopolysaccharide-induced interleukin-6 production by the kappa opioid U50,488 in a mouse monocyte-like cell line.

Parkhill AL, Bidlack JM.

Int Immunopharmacol. 2006 Jun;6(6):1013-9. Epub 2006 Feb 17.

PMID:
16644488
[PubMed - indexed for MEDLINE]
2.

Inhibition of interleukin-1 and tumor necrosis factor-alpha synthesis following treatment of macrophages with the kappa opioid agonist U50, 488H.

Belkowski SM, Alicea C, Eisenstein TK, Adler MW, Rogers TJ.

J Pharmacol Exp Ther. 1995 Jun;273(3):1491-6.

PMID:
7791124
[PubMed - indexed for MEDLINE]
3.

Blockade of mu-opioid receptor-mediated G-protein activation and antinociception by TRK-820 in mice.

Mizoguchi H, Hung KC, Leitermann R, Narita M, Nagase H, Suzuki T, Tseng LF.

Eur J Pharmacol. 2003 Feb 7;461(1):35-9.

PMID:
12568913
[PubMed - indexed for MEDLINE]
4.

Kappa-opioid potentiation of tumor necrosis factor-alpha-induced anti-HIV-1 activity in acutely infected human brain cell cultures.

Chao CC, Gekker G, Hu S, Kravitz F, Peterson PK.

Biochem Pharmacol. 1998 Aug 1;56(3):397-404.

PMID:
9744578
[PubMed - indexed for MEDLINE]
5.

Inhibition of primary murine macrophage cytokine production in vitro following treatment with the kappa-opioid agonist U50,488H.

Alicea C, Belkowski S, Eisenstein TK, Adler MW, Rogers TJ.

J Neuroimmunol. 1996 Jan;64(1):83-90.

PMID:
8598393
[PubMed - indexed for MEDLINE]
6.

Augmenting effect of opioids on nitrite production by stimulated murine macrophages.

Kowalski J.

Neuropeptides. 1998 Jun;32(3):287-91.

PMID:
10189065
[PubMed - indexed for MEDLINE]
7.

Kappa-opioid receptors on lymphocytes of a human lymphocytic cell line: morphine-induced up-regulation as evidenced by competitive RT-PCR and indirect immunofluorescence.

Suzuki S, Chuang LF, Doi RH, Bidlack JM, Chuang RY.

Int Immunopharmacol. 2001 Sep;1(9-10):1733-42.

PMID:
11562065
[PubMed - indexed for MEDLINE]
8.

Opioid-mediated modulation of calcium currents in striatal and pallidal neurons following reserpine treatment: focus on kappa response.

Spadoni F, Martella G, Martorana A, Lavaroni F, D'Angelo V, Bernardi G, Stefani A.

Synapse. 2004 Mar 1;51(3):194-205.

PMID:
14666517
[PubMed - indexed for MEDLINE]
9.

Dynorphin selectively augments the M-current in hippocampal CA1 neurons by an opiate receptor mechanism.

Madamba SG, Schweitzer P, Siggins GR.

J Neurophysiol. 1999 Oct;82(4):1768-75.

PMID:
10515966
[PubMed - indexed for MEDLINE]
Free Article
10.

Inhibition of lipopolysaccharide-induced nitric oxide and cytokine production by ultralow concentrations of dynorphins in mixed glia cultures.

Kong LY, McMillian MK, Hudson PM, Jin L, Hong JS.

J Pharmacol Exp Ther. 1997 Jan;280(1):61-6.

PMID:
8996182
[PubMed - indexed for MEDLINE]
Free Article
11.

The kappa-opioid antagonist GNTI reduces U50,488-, DAMGO-, and deprivation-induced feeding, but not butorphanol- and neuropeptide Y-induced feeding in rats.

Jewett DC, Grace MK, Jones RM, Billington CJ, Portoghese PS, Levine AS.

Brain Res. 2001 Aug 3;909(1-2):75-80.

PMID:
11478923
[PubMed - indexed for MEDLINE]
12.

Opioid-dopamine interaction in planaria: a behavioral study.

Passarelli F, Merante A, Pontieri FE, Margotta V, Venturini G, Palladini G.

Comp Biochem Physiol C Pharmacol Toxicol Endocrinol. 1999 Sep;124(1):51-5.

PMID:
10579648
[PubMed - indexed for MEDLINE]
13.

Administration of mu-, kappa- or delta2-receptor agonists via osmotic minipumps suppresses murine splenic antibody responses.

Rahim RT, Meissler JJ Jr, Cowan A, Rogers TJ, Geller EB, Gaughan J, Adler MW, Eisenstein TK.

Int Immunopharmacol. 2001 Oct;1(11):2001-9.

PMID:
11606031
[PubMed - indexed for MEDLINE]
14.
15.

Suppression by nor-binaltorphimine of kappa opioid-mediated diuresis in rats.

Takemori AE, Schwartz MM, Portoghese PS.

J Pharmacol Exp Ther. 1988 Dec;247(3):971-4.

PMID:
2849679
[PubMed - indexed for MEDLINE]
16.

kappa-Opioid receptor stimulation inhibits augmentation of Ca(2+) transient and hypertrophy induced by isoprenaline in neonatal rat ventricular myocytes - Role of CaMKIIdelta(B).

Wu G, Wang H, Yang J, Yang Y, Liu C, Jing L, Wong TM.

Eur J Pharmacol. 2008 Oct 24;595(1-3):52-7. doi: 10.1016/j.ejphar.2008.07.059. Epub 2008 Aug 5.

PMID:
18721804
[PubMed - indexed for MEDLINE]
17.

The kappa opioid receptor expressed on the mouse R1.1 thymoma cell line down-regulates without desensitizing during chronic opioid exposure.

Joseph DB, Bidlack JM.

J Pharmacol Exp Ther. 1995 Mar;272(3):970-6.

PMID:
7891351
[PubMed - indexed for MEDLINE]
18.

Effects of the kappa opioid agonist U50,488 and the kappa opioid antagonist nor-binaltorphimine on choice between cocaine and food in rhesus monkeys.

Negus SS.

Psychopharmacology (Berl). 2004 Nov;176(2):204-13. Epub 2004 Apr 27.

PMID:
15112031
[PubMed - indexed for MEDLINE]
19.

Inhibition of T cell superantigen responses following treatment with the kappa-opioid agonist U50,488H.

Guan L, Eisenstein TK, Adler MW, Rogers TJ.

J Neuroimmunol. 1997 May;75(1-2):163-8.

PMID:
9143250
[PubMed - indexed for MEDLINE]
20.

The selective kappa-opioid receptor agonist U50,488H attenuates voluntary ethanol intake in the rat.

Lindholm S, Werme M, Brené S, Franck J.

Behav Brain Res. 2001 May;120(2):137-46.

PMID:
11182162
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk